Related Experiment Video
Updated: May 21, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
[Cystic fibrosis newborn screening: management issues]
1Association Française pour le Dépistage et la Prévention des handicaps de l'Enfant (AFDPHE), 38 rue Cauchy, 75015 Paris, France. anne.munck@rdb.aphp.fr
Newborn screening for cystic fibrosis (CF) aids early detection but requires improved follow-up care to prevent complications. Research is crucial for refining diagnostic and treatment strategies for infants with CF and atypical CF diagnoses.
Area of Science:
- Pediatrics
- Genetics
- Pulmonology
Context:
- Newborn screening (NBS) identifies pre-symptomatic cystic fibrosis (CF) cases.
- Challenges include managing nutritional and pulmonary complications in infants.
- Atypical CF diagnoses present diagnostic and prognostic dilemmas for clinicians and families.
Purpose:
- To review current recommendations for follow-up care and treatment of infants identified through NBS.
- To highlight the need for harmonized practices among CF care specialists.
- To emphasize the importance of clinical trials for young CF patients.
Summary:
- NBS facilitates early detection of CF, but effective follow-up is critical to prevent complications.
- Expert consensus provides guidance on managing infants with confirmed or atypical CF diagnoses.
- Clinical trials are essential for developing accurate outcome measures for pulmonary function in infants.
Impact:
- Aims to improve care coordination and outcomes for newborns with CF.
- Supports the development of evidence-based guidelines for CF management.
- Encourages clinical research to address knowledge gaps in pediatric CF care.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

